- Home
- CGON vs DNN Comparison
CGON vs DNN Comparison
Compare CGON & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- DNN
- Stock Information
- Founded
- CGON 2010
- DNN 1936
- Country
- CGON United States
- DNN Canada
- Employees
- CGON N/A
- DNN N/A
- Industry
- CGON
- DNN Other Metals and Minerals
- Sector
- CGON
- DNN Basic Materials
- Exchange
- CGON NYSE
- DNN Nasdaq
- Market Cap
- CGON 2.3B
- DNN 1.8B
- IPO Year
- CGON 2024
- DNN 1997
- Fundamental
- Price
- CGON $29.08
- DNN $1.88
- Analyst Decision
- CGON Strong Buy
- DNN Strong Buy
- Analyst Count
- CGON 10
- DNN 2
- Target Price
- CGON $65.11
- DNN $3.00
- AVG Volume (30 Days)
- CGON 809.2K
- DNN 25.0M
- Earning Date
- CGON 02-02-2025
- DNN 02-27-2025
- Dividend Yield
- CGON N/A
- DNN N/A
- EPS Growth
- CGON N/A
- DNN N/A
- EPS
- CGON N/A
- DNN N/A
- Revenue
- CGON $684,000.00
- DNN $2,920,167.00
- Revenue This Year
- CGON $210.00
- DNN $226.79
- Revenue Next Year
- CGON N/A
- DNN $133.88
- P/E Ratio
- CGON N/A
- DNN N/A
- Revenue Growth
- CGON 258.12
- DNN N/A
- 52 Week Low
- CGON $25.77
- DNN $1.40
- 52 Week High
- CGON $50.23
- DNN $2.47
- Technical
- Relative Strength Index (RSI)
- CGON 44.86
- DNN 41.80
- Support Level
- CGON $27.70
- DNN $1.89
- Resistance Level
- CGON $29.69
- DNN $1.98
- Average True Range (ATR)
- CGON 1.43
- DNN 0.10
- MACD
- CGON 0.16
- DNN -0.00
- Stochastic Oscillator
- CGON 31.29
- DNN 22.50
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.